Malcolm Evans is a corporate associate in the New York office of Latham & Watkins and a member of the Mergers & Acquisitions Practice.

Malcolm advises public and private companies, private equity funds, and strategic investors on a wide range of transactions in a broad cross-section of industries, including sports and entertainment. His practice includes advising on public and private M&A transactions, joint ventures, co-investments, restructuring transactions, and general corporate matters, including corporate governance.

Prior to joining Latham, Malcolm worked at a preeminent sports and entertainment company and as a corporate associate for another leading New York law firm. 

Prior to his legal career, Malcolm worked on Wall Street, representing investment managers in structuring and syndicating collateralized loan obligations.  

Malcolm’s experience includes advising:

  • Transocean Ltd on its pending US$5.8 billion acquisition of Valaris Limited*
  • ERT, a Macquarie Capital–backed company, in its acquisition of Sev1Tech*
  • David Rubenstein in his US$1.7 billion acquisition of the Baltimore Orioles*
  • Michael Jordan and Hornets Sports & Entertainment in the sale of the Charlotte Hornets to a group led by Gabe Plotkin and Rick Schnall*
  • Michael Jordan in the sale of a minority interest in the Charlotte Hornets to Gabe Plotkin*
  • Hornets Sports & Entertainment in connection with certain employment-related matters*
  • The Carlyle Group’s affiliated funds in their sale of the Traxys Group to Optiver, Traxys’ management, and other investors*
  • Apollo Global Management’s affiliated funds:
    • In their acquisition of Tenneco Inc. at an enterprise valuation of US$7.1 billion*
    • In their acquisition of Tech Data Corporation at an enterprise valuation of US$6 billion*
  • Snap Inc. in connection with the negotiation of governance matters relating to the employment and founder status of Evan Spiegel and Robert Murphy*
  • Mallinckrodt plc in its sale of its Therakos business; its reorganization process, Chapter 11 bankruptcy emergence, and satisfaction of debt obligations; and its earlier debt restructuring and resolution of opioid-related claims and Acthar Gel litigation through a voluntary chapter 11* 
  • Evernorth, the leading health services portfolio of Cigna, in its acquisition of MDLIVE*
  • Alexion Pharmaceuticals in its sale to AstraZeneca* 
  • Cigna Ventures in its investment in Bright Health Group* 
  • Nasdaq in its acquisition of Verafin*
  • Pfizer in its acquisition of Array BioPharma* 

*Matter handled prior to joining Latham  

Bar Qualification

  • New York

Education

  • JD, Columbia Law School, 2018
    James Kent Scholar, Jane Marks Murphy Prize
  • BS in Economics, University of Pennsylvania, Wharton School of Business, 2011
    cum laude